Heart Failure
From the Journals
Antibody linked to spontaneous reversal of ATTR-CM
“We are very optimistic about this discovery of these antibodies. They could become the first treatment to clear the amyloid that causes this...
Conference Coverage
Big boost in sodium excretion with HF diuretic protocol
“The protocol is feasible, safe, and very effective. Cardiologists might consider how to implement a similar protocol in their center to improve...
Conference Coverage
First-line or BiV backup? Conduction system pacing for CRT in heart failure
CSP is “a long way” from replacing conventional CRT, but the new studies at the HRS sessions should help extend His-bundle and LBB-area pacing to...
Conference Coverage
Dapagliflozin matches non–loop diuretic for congestion in AHF: DAPA-RESIST
“The next steps are to assess whether a strategy of using SGLT2 inhibitors up front in patients with HF reduces the incidence of diuretic...
Latest News
Medicaid patients with heart failure get poor follow-up after hospital discharge
Both structural racism and problems with access are likely behind the low rates of follow-up care.
Conference Coverage
EHR nudges a bust for boosting guideline-directed meds in acute HF: PROMPT-AHF
“I do think that a lot of the clinicians were thinking, ‘I’m just going to get this patient out and someone in the outside will get them on GDMT...
News from the FDA/CDC
FDA OKs Injectafer for iron deficiency anemia in heart failure
“This new indication for Injectafer marks the first and only FDA approval of an intravenous iron replacement therapy for adult patients with heart...
News from the FDA/CDC
FDA approves new drug, sotagliflozin, for heart failure
“It will be a reasonably tall task for sotagliflozin to come from behind and be disruptive in a space where there are already two well-established...
From the Journals
Circulatory support for RV failure caused by pulmonary embolism
A new review highlights three mechanical circulatory support options in high-risk patients, but teamwork is key.
Conference Coverage
ARNI bests ARB to reduce NT-proBNP in stabilized preserved-EF HF
“Hopefully, these trial data help strengthen clinicians’ resolve to prescribe sacubitril-valsartan to a growing population of vulnerable patients...
Conference Coverage
Trientine reduces NT-proBNP up to 8 weeks in HFrEF: TRACER-HF
“It is always exciting to consider new pathways to treat patients with systolic dysfunction, given the residual risk even for patients on...